BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33741764)

  • 21. Undifferentiated endometrial carcinoma arising in the background of high-grade endometrial carcinoma - Expanding the definition of dedifferentiated endometrial carcinoma.
    Busca A; Parra-Herran C; Nofech-Mozes S; Djordjevic B; Ismiil N; Cesari M; Nucci MR; Mirkovic J
    Histopathology; 2020 Nov; 77(5):769-780. PubMed ID: 32557836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
    Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
    Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRG1, INI1, and ARID1B Deficiency in Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Analysis of a Large Series From a Single Institution.
    Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
    Am J Surg Pathol; 2020 Dec; 44(12):1712-1724. PubMed ID: 32910019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma.
    Mueller JJ; Pedra Nobre S; Braxton K; Alektiar KM; Leitao MM; Aghajanian C; Ellenson LH; Abu-Rustum NR
    Gynecol Oncol; 2020 Jun; 157(3):619-623. PubMed ID: 32247604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
    Fadare O; Parkash V
    Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.
    Barlin JN; Soslow RA; Lutz M; Zhou QC; St Clair CM; Leitao MM; Iasonos A; Hensley ML; Barakat RR; Matias-Guiu X; Abu-Rustum NR
    Int J Gynecol Cancer; 2013 Nov; 23(9):1620-8. PubMed ID: 24126219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas.
    Karnezis AN; Hoang LN; Coatham M; Ravn S; Almadani N; Tessier-Cloutier B; Irving J; Meng B; Li X; Chow C; McAlpine J; Kuo KT; Mao TL; Djordjevic B; Soslow RA; Huntsman DG; Blake Gilks C; Köbel M; Lee CH
    Mod Pathol; 2016 Mar; 29(3):302-14. PubMed ID: 26743474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas.
    Werner HM; Berg A; Wik E; Birkeland E; Krakstad C; Kusonmano K; Petersen K; Kalland KH; Oyan AM; Akslen LA; Trovik J; Salvesen HB
    Mod Pathol; 2013 Mar; 26(3):428-34. PubMed ID: 23080032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms.
    Tafe LJ; Garg K; Chew I; Tornos C; Soslow RA
    Mod Pathol; 2010 Jun; 23(6):781-9. PubMed ID: 20305618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the Uterine Corpus are Characterized by CTNNB1 Mutations and Can Show Adverse Clinical Outcomes.
    Ladwig NR; Umetsu SE; Zaloudek C; Rabban J; Garg K
    Int J Gynecol Pathol; 2021 Mar; 40(2):103-115. PubMed ID: 32909971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pitfall in the diagnosis of endometrial cancer: case report of an endometrioid adenocarcinoma arising from uterine adenomyosis.
    Boes AS; Tousseyn T; Vandenput I; Timmerman D; Vergote I; Moerman P; Amant F
    Eur J Gynaecol Oncol; 2011; 32(4):431-4. PubMed ID: 21941970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endometrioid Endometrial Carcinoma With Spindle Cells-Aberrant p16 and p53 Expression.
    Sonawane S; Elfituri O; Zhang Y; Yordan E; Ree N
    Int J Surg Pathol; 2019 Apr; 27(2):203-207. PubMed ID: 29953305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
    Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
    J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometrial metastasis of colorectal cancer with coincident endometrial adenocarcinoma.
    Colling R; Lopes T; Das N; Mathew J
    BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22791861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synchronous ovarian endometrioid adenocarcinoma with a functioning stroma and endometrial endometrioid adenocarcinoma by different loss of heterozygosity findings.
    Takai N; Kai K; Tsuno A; Nasu K; Kashima K; Narahara H
    Arch Gynecol Obstet; 2011 Oct; 284(4):951-5. PubMed ID: 21046134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
    Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
    Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
    Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
    Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometrioid Endometrial Carcinoma With NKX3.1 Expression in a Transgender Man: A Case Report.
    Yoshida H; Uno M; Ogimoto K; Kobayashi-Kato M; Tanase Y; Ishikawa M; Kato T
    Int J Gynecol Pathol; 2023 May; 42(3):308-314. PubMed ID: 36811847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic study of endometrial dedifferentiated endometrioid adenocarcinoma: a case report.
    Shen Y; Wang Y; Shi Y; Liu J; Liu Y
    Int J Clin Exp Pathol; 2012; 5(1):77-82. PubMed ID: 22295150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.